Lessons learned: new insights on the role of cytokines in COVID-19

Nat Immunol. 2021 Apr;22(4):404-411. doi: 10.1038/s41590-021-00901-9.

Abstract

In the midst of resurging COVID-19 cases, the second NIH/FDA virtual COVID-19 and Cytokines symposium was held on 1 December 2020, focusing on longitudinal studies of COVID-19 immunity, including long-term consequences, potential associations with autoimmunity and the multisystem inflammatory syndrome in children (MIS-C).

Publication types

  • Congress
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Age Factors
  • Animals
  • Autoimmunity
  • Biomedical Research*
  • COVID-19 / immunology*
  • COVID-19 / metabolism
  • COVID-19 / therapy
  • COVID-19 / virology
  • Cytokine Release Syndrome / immunology*
  • Cytokine Release Syndrome / metabolism
  • Cytokine Release Syndrome / virology
  • Cytokines / immunology*
  • Cytokines / metabolism
  • Host-Pathogen Interactions
  • Humans
  • Immune System / immunology*
  • Immune System / metabolism
  • Immune System / virology
  • Prognosis
  • Risk Factors
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / pathogenicity
  • Systemic Inflammatory Response Syndrome / immunology*
  • Systemic Inflammatory Response Syndrome / metabolism
  • Systemic Inflammatory Response Syndrome / therapy
  • Systemic Inflammatory Response Syndrome / virology

Substances

  • Cytokines

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related